NEXENTIS TECHNOLOGIES INC. Inventory
NEXENTIS TECHNOLOGIES INC. (NXTS) had Inventory of $16.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2025-11-13
- 2025-09-30: Inventory, Net $16.00K.
- 2025-06-30: Inventory, Net $16.00K.
- 2025-03-31: Inventory, Net $15.00K.
- 2024-12-31: Inventory, Net $21.00K.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2025-09-30 | $16.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $16.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $15.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $21.00K 10-Q · filed 2025-11-13 | |
| 2024-09-30 | $50.91K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $106.34K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $103.99K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $122.00K 10-K · filed 2025-03-31 | $121.51K 10-K · filed 2024-04-01 |
| 2023-09-30 | $90.76K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $91.70K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $90.10K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $81.71K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $84.86K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $36.30K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $26.57K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $22.60K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $17.97K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $15.24K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $15.98K 10-Q · filed 2021-05-18 | |
| 2020-12-31 | $16.36K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $11.27K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $11.27K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $11.27K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $16.30K 10-K · filed 2021-03-29 | |
| 2018-12-31 | $38.09K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |